跳到正文
原文
Endpoints News 生物医药· Tom Randall·· 16 天前AI 评分31

中国成为生物科技担忧焦点,大型药企继续采购管线

China climbed biotech's worry list, while Big Pharma kept shopping

AI 导读

在美国财政部即将发布限制对华生物科技投资的草案规则前,生物科技公司对中国的担忧增加,而大型药企仍在积极采购其管线产品。

正文

November 4, 2026 10:35 AM EST

Biotech turns on Chi­na while Big Phar­ma keeps shop­ping its pipeline: Sig­nal Sur­vey

In the months lead­ing up to the Trea­sury De­part­ment’s re­lease of draft rules that would lim­it US in­vest­ment in Chi­nese bio­phar­ma, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Think we're worth reading - tell Google.

Confirm Endpoints as a trusted biopharma news source

Confirm on Google

ENDPOINTS CAREERS

来源:Endpoints News 生物医药 · endpoints.news